• Home
  • NEW DAY MEDICINE
  • 2(40)2022
  • 96 -2 (40) 2022 — Kasymova R.I., Abdieva R.M. — THE PROBLEM OF SARCOPENIA AMONG PATIENTS WITH LIVER CIRRHOSIS OF VIRAL ETIOLOGY

96 -2 (40) 2022 — Kasymova R.I., Abdieva R.M. — THE PROBLEM OF SARCOPENIA AMONG PATIENTS WITH LIVER CIRRHOSIS OF VIRAL ETIOLOGY

THE PROBLEM OF SARCOPENIA AMONG PATIENTS WITH LIVER CIRRHOSIS OF VIRAL ETIOLOGY

Kasymova R.I., Research Institute of Virology RSNPMTSEMIPZ Tashkent city, Uzbekistan

Abdieva R.M. Research Institute of Virology RSNPMTSEMIPZ Tashkent city, Uzbekistan

Resume

The aim of the study was to study the presence of sarcopenia in patients with cirrhosis of the liver of viral etiology and its prevalence depending on the type of viral hepatitis, gender and Child-Pugh class. The selection of patients was carried out from the 4th quarter of 2019 to the 1st quarter of 2020 and from 2021-2022 on the basis of the clinic of the Research Institute of Virology in Tashkent. In the course of the study, dynamometry turned out to be the main one in assessing sarcopenia at the primary stage. With cirrhosis of the liver of class “A” sarcopenia was observed in 6.70% of cases in men and 75% in women; class “B” – in 27.30% and 80%; class “C” – in 67.70% and 100%. When comparing groups by etiology, the indicators were not statistically significant (p>0.05). Based on the data obtained, in assessing sarcopenia at the primary stage, we can rely only on dynamometry indicators.

Key words: sarcopenia, cirrhosis of the liver, frequency of occurrence in cirrhosis, liver transplantation.

First page

485

Last page

490

For citation: Kasymova R.I., Abdieva R.M. THE PROBLEM OF SARCOPENIA AMONG PATIENTS WITH LIVER CIRRHOSIS OF VIRAL ETIOLOGY //New Day in Medicine 2(40)2022 485-490 https://clck.ru/eSSe8

LIST OF REFERENCES:

  1. Asrani S.K., Devarbhavi H., Eaton J., Kamath P.S. Burden of liver diseases in the world. J. Hepatol. 2019; 70:151–171. doi: 10.1016/j.jhep.2018.09.014.
  2. Palmer L.B., Kuftinec G., Pearlman M., Green C.H. Nutrition in Cirrhosis. Curr. Gastroenterol. Rep. 2019; 21:38. doi: 10.1007/s11894-019-0706-5. 
  3. Song Y.N., Chen J., Cai F.F., Lu Y.Y., Chen Q.L., Zhang Y.Y., Liu P., Su S.B. A metabolic mechanism analysis of Fuzheng-Huayu formula for improving liver cirrhosis with traditional Chinese medicine syndromes. Acta Pharmacol. Sin. 2018; 39:942–951. doi: 10.1038/aps.2017.101.
  4. World Health Organization Global Hepatitis Report 2017. [(accessed on 3 July2020)];
  5. Fatuma Meyer, Karen Bannert,Mats Wiese, Susanne Esau Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis //Int J Mol Sci. 2020 Aug; 21(15): 5357. doi: 10.3390/ijms21155357
  6. Rungta S., Deep A., Swaroop S. Malnutrition in Liver Cirrhosis: A Review. J. Clin. Diag. Res. 2019; 13:OE01–OE05. doi: 10.7860/JCDR/2019/38412.12822.
  7. Nishikawa H., Shiraki M., Hiramatsu A., Moriya K., Hino K., Nishiguchi S. Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol. Res. 2016; 46:951–963. doi: 10.1111/hepr.12774. 
  8. Bémeur C., Desjardins P., Butterworth R. Role of Nutrition in the Management of Hepatic Encephalopathy in End-Stage Liver Failure. J. Nutr. Metab. 2010; 2010:1–12. doi: 10.1155/2010/489823. 
  9. Bémeur C., Butterworth R.F. Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications. J. Clin. Exp. Hepatol. 2015; 5:S131–S140. doi: 10.1016/j.jceh.2015.02.004. 
  10. Theodoridis X., Grammatikopoulou M.G., Petalidou A., Kontonika S.-M., Potamianos S.P., Bogdanos D.P. A Systematic Review of Medical Nutrition Therapy Guidelines for Liver Cirrhosis: Do We Agree? Nutr. Clin. Pr. 2019; 35:98–107. doi: 10.1002/ncp.10393. 
  11. Rachakonda V., Borhani A.A., Dunn M.A., Andrzejewski M., Martin K., Behari J. Serum Leptin Is a Biomarker of Malnutrition in Decompensated Cirrhosis. PLoS ONE. 2016; 11:e0159142. doi: 10.1371/journal.pone.015914
  12. Eghtesad S., Poustchi H., Malekzadeh R. Malnutrition in Liver Cirrhosis: The Influence of Protein and Sodium. Middle East J. Dig. Dis. 2013; 5:65–75.
  13. Chawla Y., Bodh V. Clinical clues to the diagnosis of cirrhosis. In: Samuel S.L., Richard M., editors. Cirrhosis: A Practical Guide to Management. John Wiley & Sons, Ltd.; Chichester, UK: 2015. pp. 1–11. 
  14. Journal of gepatology 2018 EASL Clinical Practice Guidelines on nutrition in chronic liver disease.
  15. Мерли М., Джусто М., Джентили Ф., Новелли Дж., Ферретти Дж., Риджио О и др. Статус питания: его влияние на исход пациентов, перенесших трансплантацию печени. Liver Int. 2010; 30: 208-214;
  16. Montano-Loza A.J. Клиническая значимость саркопении у пациентов с циррозом печени. World J Gastroenterol.. 2014; 20: 8061-8071;
  17. Энглсбе М.Дж., Патель С.П., Хе К., Линч Р.Дж., Шаубель Д.Е., Харбо С. и др. Саркопения и смертность после трансплантации печени. J Am Coll Surg. 2010; 211: 271-278.
  18. Kalaitzakis E., Bosaeus I., Öhman L., Björnsson E. Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: Correlations with energy intake and resting energy expenditure. Am. J. Clin. Nutr. 2007; 85:808–815. doi: 10.1093/ajcn/85.3.808. 
  19. Bunchorntavakul C., Reddy K. Review article: Malnutrition/sarcopenia and frailty in patients with cirrhosis. Aliment. Pharmacol. Ther. 2019; 51:64–77. doi: 10.1111/apt.15571. 
  20. Rachakonda V., Borhani A.A., Dunn M.A., Andrzejewski M., Martin K., Behari J. Serum Leptin Is a Biomarker of Malnutrition in Decompensated Cirrhosis. PLoS ONE. 2016; 11:e0159142. doi: 10.1371/journal.pone.0159142.

file

download